Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 26.80
+0.20 (0.75%)
Jun 30, 2026, 4:59 PM CET
Embla Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Embla Medical stock has a consensus rating of "Buy" and an average price target of kr 33.30. The average 1-year stock price forecast is 24.25% higher than the current stock price, while the lowest is kr 29.00 (+8.21%) and the highest is kr 40.00 (+49.25%).
Price Target: kr 33.30 (+24.25%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Embla Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
1.02B
from 928.69M
Increased by 9.72%
Revenue Next Year
1.10B
from 1.02B
Increased by 8.03%
EPS This Year
1.45
from 1.24
Increased by 17.00%
EPS Next Year
1.71
from 1.45
Increased by 17.87%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | ||
| Avg | 1.0B | ||
| Low | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.6% | ||
| Avg | 9.7% | ||
| Low | 9.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.48 | ||
| Avg | 1.45 | ||
| Low | 1.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.3% | ||
| Avg | 17.0% | ||
| Low | 12.6% |